A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study (Q78214499)
Jump to navigation
Jump to search
scientific article published on 01 September 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study |
scientific article published on 01 September 1999 |
Statements
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study (English)
C Karanes
K J Kopecky
D R Head
M R Grever
H E Hynes
E H Kraut
R H Vial
A Lichtin
S Nand
1 September 1999